EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CK2 activity is crucial for proper glucagon expression

Emmanuel Ampofo, Mandy Pack, Selina Wrublewsky, Anne S Boewe, Aliya F Spigelman, Hanna Koch, Patrick E MacDonald, Matthias W Laschke, Mathias Montenarh, Claudia Götz

Diabetologia · 2024

DOI: 10.1007/s00125-024-06128-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2024. Verfasst von Emmanuel Ampofo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany. Hauptthemen laut MEDLINE: Casein Kinase II, Glucagon, Glucagon-Secreting Cells, Homeodomain Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Rolf M. Schwiete Stiftung, Mannheim, Germany, Universität des Saarlandes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Protein kinase CK2 acts as a negative regulator of insulin expression in pancreatic beta cells. This action is mainly mediated by phosphorylation of the transcription factor pancreatic and duodenal homeobox protein 1 (PDX1). In pancreatic alpha cells, PDX1 acts in a reciprocal fashion on glucagon (GCG) expression. Therefore, we hypothesised that CK2 might positively regulate GCG expression in pancreatic alpha cells.

Methods

We suppressed CK2 kinase activity in αTC1 cells by two pharmacological inhibitors and by the CRISPR/Cas9 technique. Subsequently, we analysed GCG expression and secretion by real-time quantitative RT-PCR, western blot, luciferase assay, ELISA and DNA pull-down assays. We additionally studied paracrine effects on GCG secretion in pseudoislets, isolated murine islets and human islets. In vivo, we examined the effect of CK2 inhibition on blood glucose levels by systemic and alpha cell-specific CK2 inhibition.

Results

We found that CK2 downregulation reduces GCG secretion in the murine alpha cell line αTC1 (e.g. from 1094±124 ng/l to 459±110 ng/l) by the use of the CK2-inhibitor SGC-CK2-1. This was due to a marked decrease in Gcg gene expression through alteration of the binding of paired box protein 6 (PAX6) and transcription factor MafB to the Gcg promoter. The analysis of the underlying mechanisms revealed that both transcription factors are displaced by PDX1. Ex vivo experiments in isolated murine islets and pseudoislets further demonstrated that CK2-mediated reduction in GCG secretion was only slightly affected by the higher insulin secretion after CK2 inhibition. The kidney capsule transplantation model showed the significance of CK2 for GCG expression and secretion in vivo. Finally, CK2 downregulation also reduced the GCG secretion in islets isolated from humans. Conclusions/interpretation These novel findings not only indicate an important function of protein kinase CK2 for proper GCG expression but also demonstrate that CK2 may be a promising target for the development of novel glucose-lowering drugs. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Casein Kinase IIGlucagonGlucagon-Secreting CellsHomeodomain ProteinsAnimalsHumansMiceCell LineInsulinTrans-Activators

Stichwörter der Autor:innen

GlucagonGlucose homeostasisPDX1Pancreatic alpha cellsProtein kinase CK2

Substanzen

Casein Kinase IIGlucagonHomeodomain ProteinsInsulinpancreatic and duodenal homeobox 1 proteinTrans-Activators

Autor:innen und Institutionen

  • Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
  • Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany.
  • Department of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.
  • Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany. c.goetz@mx.uni-saarland.de.

Förderung

  • Dr. Rolf M. Schwiete Stiftung, Mannheim, Germany
  • Universität des Saarlandes

Zitieren

APA

Ampofo, E., Pack, M., Wrublewsky, S., Boewe, A. S., Spigelman, A. F., Koch, H., MacDonald, P. E., Laschke, M. W., Montenarh, M., & Götz, C. (2024). CK2 activity is crucial for proper glucagon expression. Diabetologia. https://doi.org/10.1007/s00125-024-06128-1

Vancouver

Ampofo E, Pack M, Wrublewsky S, Boewe AS, Spigelman AF, Koch H, et al. CK2 activity is crucial for proper glucagon expression. Diabetologia. 2024. doi:10.1007/s00125-024-06128-1

BibTeX
@article{Ampofo2024,
  author = {Ampofo, Emmanuel and Pack, Mandy and Wrublewsky, Selina and Boewe, Anne S and Spigelman, Aliya F and Koch, Hanna and MacDonald, Patrick E and Laschke, Matthias W and Montenarh, Mathias and Götz, Claudia},
  title = {CK2 activity is crucial for proper glucagon expression},
  journal = {Diabetologia},
  year = {2024},
  doi = {10.1007/s00125-024-06128-1}
}
Kostenlos starten →